Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-03-14 | 2017-03-28 | 2603 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-05-30 | 2017-07-18 | 11491 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2021-09-20 | 2021-09-28 | 145907 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2021-10-19 | 2021-11-16 | 147573 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2018-04-19 | 2018-04-30 | 46589 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2018-11-26 | 2020-03-30 | 67602 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2024-02-26 | 2024-10-30 | 220548 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2022-10-19 | 2022-12-28 | 172178 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2022-04-06 | 2022-09-27 | 158046 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2023-12-19 | 2024-01-06 | 213882 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Avoided shortage | 2024-08-08 | 2024-08-15 | 234800 |
| PAPAVERINE HYDROCHLORIDE INJECTION USP | 65MG | LIQUID | Resolved | 2022-12-28 | 2023-03-14 | 179515 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2023-02-09 | 2023-03-04 | 184259 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2022-03-25 | 2022-04-20 | 157419 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2022-09-01 | 2022-10-05 | 168452 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2017-03-14 | 2017-07-05 | 2586 |
| PHENOBARBITAL SODIUM INJECTION, USP | 30MG | SOLUTION | Resolved | 2017-07-11 | 2017-10-27 | 15463 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2019-10-15 | 2019-11-01 | 96570 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2024-03-11 | 2024-04-24 | 221838 |
| PHENOBARBITAL SODIUM INJECTION, USP | 120MG | SOLUTION | Resolved | 2024-06-03 | 2024-06-13 | 229498 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |